122 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
, full-time employee, consultant or member of the Scientific Advisory Board of the Company and its affiliates. For greater certainty, the optionee shall … employee no longer employed by the Company, and vest immediately upon being granted to such persons. Upon redemption, the value of the DSUs credited
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
an employee bonus pool in the aggregate amount of $4,000,000. The determination of participants, individual allocations, and payment terms (including … for surrendering securities or other enhancements in benefits related to services as an employee, director or consultant of the Company. MI 61-101 excludes
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
with respect to any current or former Company Associate or other Contract with a union or employee association, including a neutrality or accretion … Engagement Letter” has the meaning set forth in Section 32 of Schedule C.
“Company Associate” means each current or former officer or other employee
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
thereto, shall expire and terminate immediately upon an optionee ceasing to be a director, full-time employee, consultant or member of the Scientific … . The DSUs are redeemable once a Board member is no longer a member of the Board or a designated employee no longer employed by the Company, and vest
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
employee misconduct or business noncompliance, and the precautions we take to detect and prevent inappropriate conduct may not be effective … of United States dollars, except per share data, unless otherwise noted)
Significant accounting policies (continued):
Employee benefits:
Short-term
SUPPL
vdiqyupt2a
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
ftq0kogf1zxlkgw2jlh
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
mry1sgp5pzbhb5r5
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
vx98ob
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
bzi4ld 0svn
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
kfuwpe1iathpw 59kqv
13 Jul 22
Supplemental materials (foreign)
5:01pm
S-8
q8eacfj
19 Apr 22
Registration of securities for employees
4:14pm
S-8 POS
EX-4.1
nz45i mqjkvny5vw0y
19 Apr 22
Registration of securities for employees (post-effective amendment)
4:10pm
S-8 POS
EX-4.1
57sgr2n t03v132p
19 Apr 22
Registration of securities for employees (post-effective amendment)
4:10pm
6-K
EX-99.2
nxchoy
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
vd68opp5zcf dw
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.2
f6o0a82g80sxon2drg
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
fof4 4q8nmdvujqxu
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
vbvlu2t
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
9ozzv5jm
14 Dec 21
Registration of securities (Canada)
9:43am